Connect with us

Hi, what are you looking for?

Trending news

Piramal Pharma Solutions appoints Herve Berdou as Chief Operating Officer


Mumbai, India (ots/PRNewswire) -. * Brings 25 years of experience in
global operations and
supply chain to Piramal

* Experience working with CDMOs and innovative/generic pharmaceutical companies

* Track record of operational leadership and performance in multiple countries

The Pharma Solutions business of Piramal Pharma Limited, a leading contract development and manufacturing organization (CDMO), today announced the appointment of Herve Berdou as Chief Operating Officer of Piramal Pharma Solutions (PPS).

Mr. Berdou joins Piramal Pharma Solutions from Lonza, where he served as Global Head of Operations, Cell and Gene Technologies. He has more than two decades of experience in global supply chain, procurement and operations, including positions in manufacturing and as site manager in small and large facilities. At Lonza, Mr. Berdou managed a network of contract services sites around the world. Prior to that, he worked for a number of prestigious pharmaceutical companies, including AstraZeneca & MedImmune and Novartis. With many years of experience in both CDMO and pharma innovation/generics of drug development and manufacturing, Mr. Berdou brings an understanding of both perspectives to PPS. He is passionate about building customer-centric strategies, creating lean organizations, engaging employees through a robust and inclusive culture, and bringing out a strong sense of quality throughout the company. In his new role, Mr. Berdou will be based in the Northeast United States.

Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions, stated, “I welcome Herve to PPS and wish him every success in his new role. His extensive, deep industry and functional knowledge will help us create value for all of our stakeholders as we continue on our path of profitable growth. His experience in working with CDMOs and innovative pharmaceutical companies will enable him to understand and meet the needs of our customers and their patients. With his cross-country experience, he will provide optimal support to our team and site network in managing integrated customer projects and driving both clinical progress and commercial success. Hervere’s leadership style is in line with our values and cultural priorities.”

Mr. Berdou holds a Master’s degree (DESS) in Procurement and Supply Chain from IAE in Grenoble, France – Écoles Universitaires de Management, and a degree in Economics and Politics from Université Pierre Mendès-France.

Piramal Pharma Solutions Information:

Piramal Pharma Solutions (PPS) is a contract development and manufacturing organization (CDMO) that provides end-to-end development and manufacturing solutions for the entire lifecycle of pharmaceuticals. We serve our customers through a globally integrated network of facilities in North America, Europe and Asia. This enables us to offer a comprehensive range of services, including drug discovery solutions, process and pharmaceutical development services, clinical trial compounds, commercial supply of active pharmaceutical ingredients and finished dosage forms. We also offer specialized services such as high potency drug development and manufacturing, antibody-drug conjugations, sterile filling/finishing, peptide products and services, and potent solid oral drugs. PPS also provides development and manufacturing services for biologics, including vaccines, gene therapies, and monoclonal antibodies, made possible by Piramal Pharma Limited’s investment in Yapan Bio Private Limited. Our track record as a reliable service provider with experience in various technologies makes us a preferred partner for innovative and generic companies worldwide.

For more information, please visit | Twitter | LinkedIn

Piramal Pharma Ltd. information

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services manufactured in 15 global manufacturing facilities and through a global distribution network in over 100 countries. PPL comprises: Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing business; Piramal Critical Care (PCC), a complex hospital generics business; and the Indian Consumer Healthcare business, which sells over-the-counter products. PPS provides end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug lifecycle for innovative and generic companies. PCC’s complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable analgesics and anesthetics, injectable anti-infectives and other therapies. The Indian consumer healthcare business is among the leading players in India in the self-care space and has established brands in the Indian consumer healthcare market. In addition, PPL has a joint venture with Allergan, a leading ophthalmology company in the Indian formulation market. In October 2020, the company received a growth investment from the Carlyle Group.

For more information, visit | Facebook | Twitter | LinkedIn

g_Officer__Piramal.jpg Photo:
jpg Logo:

Rajiv Banerjee,
Corporate Communications,; For investors: Anupam Jain,
Investor Relations,,
+91 9819001881

© Copyright APA-OTS Originaltext-Service GmbH and the respective sender

The post Piramal Pharma Solutions appoints Herve Berdou as Chief Operating Officer appeared first on TOP News Austria – News from Austria and around the world.


You May Also Like


BongaCams, the world’s most popular webcam site, has issued its first exclusive collection of NFTs!  The collection celebrates BongaCams’ 10th birthday coming up in...


Despite all the progress, prejudices and stereotypes are still strong in society. People often judge a person by his or her appearance, and if...


As a businessman, I am constantly in contact with friends and colleagues from across Europe. Business, of course, is global and economic integration is...

Trending news

Curb the attack! is the title of Brussels Ukraїna Review’s special issue about the threat of a full invasion of Ukraine by Russia. The...